Enhancing the infrastructure of the atherosclerosis risk in Communities (ARIC) study for cancer epidemiology research

Aric cancer

Corinne E. Joshu, John R. Barber, Josef Coresh, David J. Couper, Thomas H. Mosley, Mara Z. Vitolins, Kenneth R. Butler, Heather H. Nelson, Anna E. Prizment, Elizabeth Selvin, Janet A. Tooze, Kala Visvanathan, Aaron R. Folsom, Elizabeth A Platz

Research output: Contribution to journalArticle

Abstract

Background: We describe the expansion of the Atherosclerosis Risk in Communities (ARIC) Study into a cancer cohort. In 1987 to 1989, ARIC recruited 15,792 participants 45 to 64 years old to be sex (55% female), race (27% black), and geographically diverse. ARIC has exceptional data collected during 6 clinical visits and calls every 6 months, repeated biospecimens, and linkage to Medicare claims data. Methods: We established a Cancer Coordinating Center to implement infrastructure activities, convened a Working Group for data use, leveraged ARIC staff and procedures, and developed protocols. We initiated a cancer-specific participant contact, added questions to existing contacts, obtained permission to collect medical records and tissue, abstracted records, linked with state cancer registries, and adjudicated cases and characterizing data. Results: Through 2012, we ascertained and characterized 4,743 incident invasive, first, and subsequent primary cancers among 4,107 participants and 1,660 cancer-related deaths. We generated a total cancer incidence and mortality analytic case file, and analytic case files for bladder, breast, colorectal, liver, lung, pancreas, and prostate cancer incidence, mortality, and case fatality. Adjudication of multiple data sources improved case records and identified cancers not identified via registries. From 2013 onward, we ascertain cases from self-report coupled with medical records. Additional cancer registry linkages are planned. Conclusions: Compared with starting a new cohort, expanding a cardiovascular cohort into ARIC Cancer was an efficient strategy. Our efforts yielded enhanced case files with 25 years of follow-up. Impact: Now that the cancer infrastructure is established, ARIC is contributing its unique features to modern cancer epidemiology research.

Original languageEnglish (US)
Pages (from-to)295-305
Number of pages11
JournalCancer Epidemiology Biomarkers and Prevention
Volume27
Issue number3
DOIs
StatePublished - Mar 1 2018

Fingerprint

Atherosclerosis
Epidemiology
Research
Neoplasms
Registries
Medical Records
Mortality
Information Storage and Retrieval
Incidence
Liver Neoplasms
Medicare
Pancreatic Neoplasms
Urinary Bladder Neoplasms
Self Report
Colorectal Neoplasms
Lung Neoplasms
Prostatic Neoplasms
Breast Neoplasms

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Enhancing the infrastructure of the atherosclerosis risk in Communities (ARIC) study for cancer epidemiology research : Aric cancer. / Joshu, Corinne E.; Barber, John R.; Coresh, Josef; Couper, David J.; Mosley, Thomas H.; Vitolins, Mara Z.; Butler, Kenneth R.; Nelson, Heather H.; Prizment, Anna E.; Selvin, Elizabeth; Tooze, Janet A.; Visvanathan, Kala; Folsom, Aaron R.; Platz, Elizabeth A.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 27, No. 3, 01.03.2018, p. 295-305.

Research output: Contribution to journalArticle

Joshu, Corinne E. ; Barber, John R. ; Coresh, Josef ; Couper, David J. ; Mosley, Thomas H. ; Vitolins, Mara Z. ; Butler, Kenneth R. ; Nelson, Heather H. ; Prizment, Anna E. ; Selvin, Elizabeth ; Tooze, Janet A. ; Visvanathan, Kala ; Folsom, Aaron R. ; Platz, Elizabeth A. / Enhancing the infrastructure of the atherosclerosis risk in Communities (ARIC) study for cancer epidemiology research : Aric cancer. In: Cancer Epidemiology Biomarkers and Prevention. 2018 ; Vol. 27, No. 3. pp. 295-305.
@article{360012d26570437cb41ee94e92ff6f1d,
title = "Enhancing the infrastructure of the atherosclerosis risk in Communities (ARIC) study for cancer epidemiology research: Aric cancer",
abstract = "Background: We describe the expansion of the Atherosclerosis Risk in Communities (ARIC) Study into a cancer cohort. In 1987 to 1989, ARIC recruited 15,792 participants 45 to 64 years old to be sex (55{\%} female), race (27{\%} black), and geographically diverse. ARIC has exceptional data collected during 6 clinical visits and calls every 6 months, repeated biospecimens, and linkage to Medicare claims data. Methods: We established a Cancer Coordinating Center to implement infrastructure activities, convened a Working Group for data use, leveraged ARIC staff and procedures, and developed protocols. We initiated a cancer-specific participant contact, added questions to existing contacts, obtained permission to collect medical records and tissue, abstracted records, linked with state cancer registries, and adjudicated cases and characterizing data. Results: Through 2012, we ascertained and characterized 4,743 incident invasive, first, and subsequent primary cancers among 4,107 participants and 1,660 cancer-related deaths. We generated a total cancer incidence and mortality analytic case file, and analytic case files for bladder, breast, colorectal, liver, lung, pancreas, and prostate cancer incidence, mortality, and case fatality. Adjudication of multiple data sources improved case records and identified cancers not identified via registries. From 2013 onward, we ascertain cases from self-report coupled with medical records. Additional cancer registry linkages are planned. Conclusions: Compared with starting a new cohort, expanding a cardiovascular cohort into ARIC Cancer was an efficient strategy. Our efforts yielded enhanced case files with 25 years of follow-up. Impact: Now that the cancer infrastructure is established, ARIC is contributing its unique features to modern cancer epidemiology research.",
author = "Joshu, {Corinne E.} and Barber, {John R.} and Josef Coresh and Couper, {David J.} and Mosley, {Thomas H.} and Vitolins, {Mara Z.} and Butler, {Kenneth R.} and Nelson, {Heather H.} and Prizment, {Anna E.} and Elizabeth Selvin and Tooze, {Janet A.} and Kala Visvanathan and Folsom, {Aaron R.} and Platz, {Elizabeth A}",
year = "2018",
month = "3",
day = "1",
doi = "10.1158/1055-9965.EPI-17-0696",
language = "English (US)",
volume = "27",
pages = "295--305",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "3",

}

TY - JOUR

T1 - Enhancing the infrastructure of the atherosclerosis risk in Communities (ARIC) study for cancer epidemiology research

T2 - Aric cancer

AU - Joshu, Corinne E.

AU - Barber, John R.

AU - Coresh, Josef

AU - Couper, David J.

AU - Mosley, Thomas H.

AU - Vitolins, Mara Z.

AU - Butler, Kenneth R.

AU - Nelson, Heather H.

AU - Prizment, Anna E.

AU - Selvin, Elizabeth

AU - Tooze, Janet A.

AU - Visvanathan, Kala

AU - Folsom, Aaron R.

AU - Platz, Elizabeth A

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Background: We describe the expansion of the Atherosclerosis Risk in Communities (ARIC) Study into a cancer cohort. In 1987 to 1989, ARIC recruited 15,792 participants 45 to 64 years old to be sex (55% female), race (27% black), and geographically diverse. ARIC has exceptional data collected during 6 clinical visits and calls every 6 months, repeated biospecimens, and linkage to Medicare claims data. Methods: We established a Cancer Coordinating Center to implement infrastructure activities, convened a Working Group for data use, leveraged ARIC staff and procedures, and developed protocols. We initiated a cancer-specific participant contact, added questions to existing contacts, obtained permission to collect medical records and tissue, abstracted records, linked with state cancer registries, and adjudicated cases and characterizing data. Results: Through 2012, we ascertained and characterized 4,743 incident invasive, first, and subsequent primary cancers among 4,107 participants and 1,660 cancer-related deaths. We generated a total cancer incidence and mortality analytic case file, and analytic case files for bladder, breast, colorectal, liver, lung, pancreas, and prostate cancer incidence, mortality, and case fatality. Adjudication of multiple data sources improved case records and identified cancers not identified via registries. From 2013 onward, we ascertain cases from self-report coupled with medical records. Additional cancer registry linkages are planned. Conclusions: Compared with starting a new cohort, expanding a cardiovascular cohort into ARIC Cancer was an efficient strategy. Our efforts yielded enhanced case files with 25 years of follow-up. Impact: Now that the cancer infrastructure is established, ARIC is contributing its unique features to modern cancer epidemiology research.

AB - Background: We describe the expansion of the Atherosclerosis Risk in Communities (ARIC) Study into a cancer cohort. In 1987 to 1989, ARIC recruited 15,792 participants 45 to 64 years old to be sex (55% female), race (27% black), and geographically diverse. ARIC has exceptional data collected during 6 clinical visits and calls every 6 months, repeated biospecimens, and linkage to Medicare claims data. Methods: We established a Cancer Coordinating Center to implement infrastructure activities, convened a Working Group for data use, leveraged ARIC staff and procedures, and developed protocols. We initiated a cancer-specific participant contact, added questions to existing contacts, obtained permission to collect medical records and tissue, abstracted records, linked with state cancer registries, and adjudicated cases and characterizing data. Results: Through 2012, we ascertained and characterized 4,743 incident invasive, first, and subsequent primary cancers among 4,107 participants and 1,660 cancer-related deaths. We generated a total cancer incidence and mortality analytic case file, and analytic case files for bladder, breast, colorectal, liver, lung, pancreas, and prostate cancer incidence, mortality, and case fatality. Adjudication of multiple data sources improved case records and identified cancers not identified via registries. From 2013 onward, we ascertain cases from self-report coupled with medical records. Additional cancer registry linkages are planned. Conclusions: Compared with starting a new cohort, expanding a cardiovascular cohort into ARIC Cancer was an efficient strategy. Our efforts yielded enhanced case files with 25 years of follow-up. Impact: Now that the cancer infrastructure is established, ARIC is contributing its unique features to modern cancer epidemiology research.

UR - http://www.scopus.com/inward/record.url?scp=85045505535&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045505535&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-17-0696

DO - 10.1158/1055-9965.EPI-17-0696

M3 - Article

VL - 27

SP - 295

EP - 305

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 3

ER -